MEDUWA Declaration 2020 on Emissions of Medicines for Human and Veterinary Use

13.2.2020, Zwolle, During the Stakeholder and Partner Meeting in Zwolle, the MEDUWA Declaration 2020 on Emissions of Human and Veterinary Medicines was signed:

The undersigned partners and stakeholders of the European INTERREG-VA MEDUWA-project, declare that:
1. The emission of human and veterinary medicines (pharmaceuticals), their transformation products, and microorganisms that have become resistant to antimicrobials, affect the quality of life and should be avoided in accordance with the precautionary principle.
2. The contamination of surface, ground and drinking water, soil, food and air by these chemical and biological contaminants should be considered a public hygiene issue and should be the subject of a combined health policy of both human and veterinary medicine (the OneHealth approach).
3. It is important that the water, human and veterinary health, and agri-/aquaculture sectors co-operate to solve the issue to the extent possible at its source.
4. During the education and ongoing training of those who will be prescribing medicines more emphasis needs to be given to the topic of the environmental cycle of medicines and antimicrobial resistant micro-organisms.
5. According to the polluter pays principle and in order to lower societal costs, environmental quality objectives should be increasingly integrated in policies concerning agriculture as well as human and veterinary health of all EU member states.
6. Policies and legislation should place more emphasis on the production, use and discharge of environmentally-persistent medicines. Synthetic chemicals including medicines and their impacts still receive insufficient attention in the Water Framework Directive and all other related directives, according to their latest EU Fitness Check.
7. In addition to (inter)national governments, regional and local governments are urged to integrate policies on environment, agriculture and human/veterinary health and enable measures and pilot projects to improve the quality of ground, surface and drinking water, and soil.
8. All relevant EU funding programmes for research and development should include the development and upscaling of source-oriented solutions.
9. We will strive to continue our cross-border collaboration, and to further develop and promote MEDUWA innovations after the project ends in 2020.
10. We will keep this issue high on our respective agendas and will encourage other organisations to do the same within their local, regional, national and international networks and ask them to work together on concrete solutions.

The aim of the declaration is to stimulate cross-border cooperation between policy makers and policy advisors, researchers and private companies to take action against biological and chemical pollution from pharmaceuticals and multi-resistant bacteria in the environment, which pose an invisible threat to the environment, public health and the economy.

A detailed version of the MEDUWA Declaration 2020 on the Emission of Medicinal Products for Human and Veterinary Use in English, as well as an overview of the signatories can be found here:  MEDUWA Declaration

List of signatory parties: MEDUWA Declaration_signatory parties_30042020

If you would like to become a signatory party, please contact Alfons Uijtewaal: post[at]